PAD treatment hopes dashed

Hopes that using antibiotic treatment could ease plaque build-up in atherosclerosis or peripheral arterial disease (PAD) have been quashed by US research.

Scientists have been trying to develop an antibody against Chlamydia pneumoniae, after research indicated that this bacterium caused an inflammatory response that exacerbated atherosclerosis and PAD.

But data presented at the American Heart Association scientific sessions, was described as 'a compelling argument that C pneumoniae does not play a role in PAD that is modifiable by antibacterial therapy' by lead researcher Dr Michael Jaff, director of vascular medicine at Massachusetts General Hospital in Boston.

For the study, 145 people with PAD were given the anti-chlamydia antibiotic Rifalazil at doses of 25mg weekly for eight weeks. A further 138 patients were given placebo.

Assessment of peak walking time six months later showed Rifalazil was no better than placebo. Previous trials showed similar negative results.

AHA scientific sessions 4-7 November 2007, Orlando, Florida

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

Death rates from COVID-19 are highest among patients from BAME groups, according...

GPs face hundreds of complaints over shielding and PPE during pandemic

GPs face hundreds of complaints over shielding and PPE during pandemic

GP practices have faced hundreds of complaints over issues including shielding and...

More than 3,600 GP partners lost in four years as decline accelerates

More than 3,600 GP partners lost in four years as decline accelerates

The number of full-time equivalent (FTE) GP partners in England fell by 3,636 between...

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

Around 2.4m patients are waiting longer for cancer tests or treatment because of...

PHE report delayed on how ethnicity affects COVID-19 outcomes

PHE report delayed on how ethnicity affects COVID-19 outcomes

Public Health England (PHE) has missed its 31 May deadline for reporting on how factors...

Lockdown complacency threatens second COVID-19 spike that could 'overwhelm' NHS

Lockdown complacency threatens second COVID-19 spike that could 'overwhelm' NHS

Complacency around easing coronavirus lockdown measures could trigger a second wave...